Gilead Sciences is planning to hire industry veteran Daniel O’Day to take the helm and help the drug company revive sales and recover from a disappointing deal.
from WSJ.com: What's News US https://ift.tt/2G6fDEt
Sunday, 9 December 2018
Related Post
World Bank Critic Is Nominee to Lead LenderPresident Trump will nominate David Malpass, one of the World Bank’s sharpest critics within his ad
Dow Stages Late Rally to Keep Weekly Win Streak AliveThe Dow Jones Industrial Average pared its losses heading into the closing bell to notch its sevent
HBO CEO Resigning Amid AT&T RestructuringHBO Chairman and Chief Executive Richard Plepler said he is stepping down, a move that comes as new
The 184 MPH WomanDenise Mueller-Korenek shattered the previous land-speed record for the fastest human on a bicycle
Rewards Credit Cards Gained a Fanatic Following---Now Banks Are Pulling BackMajor perks like airfare and cash back were meant to lead to higher returns. But consumers figured
Stocks Climb Higher As Fears of Economic Slowdown SubsideIndexes rose more than 1% and finished their fourth consecutive week of gains, as encouraging data
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment
Click to see the code!
To insert emoticon you must added at least one space before the code.